Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsIndustrySplitsCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Qualigen Therapeutics, Inc. Common Stock (QLGN) Debt to Equity (2020 - 2025)

Qualigen Therapeutics, Inc. Common Stock (QLGN) debt to equity from Dec 31, 2020 to Sep 30, 2025. The current Qualigen Therapeutics, Inc. Common Stock (QLGN) debt to equity is 8.40%. You can export chart.

Debt to Equity

Debt to Equity

Annual Debt to Equity change of Qualigen Therapeutics, Inc. Common Stock (QLGN)

YearDebt to EquityChange
20240.00%
N/A
20230.00%
N/A
20220.00%
N/A
20210.00%
-100.00%
20200.77%
N/A

Comparison Qualigen Therapeutics, Inc. Common Stock (QLGN) debt to equity with competitors

Qualigen Therapeutics, Inc. Common Stock (QLGN) debt to equity is 8.40%.

TickerNameDebt to EquityUpside
DRUGBright Minds Biosciences Inc0.03%-99.68%
CMNDClearmind Medicine Inc0.10%-98.85%
ARVNArvinas Inc0.13%-98.46%
GHRSGH Research PLC0.16%-98.05%
ATHEAlterity Therapeutics Ltd0.18%-97.84%
CGONCg Oncology Inc0.27%-96.73%
PHVSPharvaris NV0.31%-96.28%
OSRHBellevue Life Sciences Acquisition Corp0.37%-95.61%
GLPGGalapagos NV0.37%-95.55%
VTVTvTv Therapeutics Inc - Class A0.46%-94.53%
LPTXLeap Therapeutics Inc0.68%-91.91%
ADXNAddex Therapeutics Ltd0.73%-91.33%
CBUSCibus Global Ltd. Class A0.75%-91.05%
ABVCABVC BioPharma Inc0.82%-90.20%
COEPCoeptis Therapeutics Holdings Inc. Common Stock0.87%-89.61%
PPCBPropanc Biopharma Inc1.05%-87.48%
ARGXArgen X SE1.14%-86.44%
OCSOculis Holding AG1.14%-86.40%
XRTXXORTX Therapeutics Inc1.17%-86.05%
IMMPImmutep Ltd1.22%-85.45%
CANFCan-Fite Biopharma Ltd1.27%-84.89%
RVPHReviva Pharmaceuticals Holdings Inc1.33%-84.22%
BNTXBioNTech SE1.62%-80.73%
NBPNovaBridge Biosciences.1.74%-79.25%
NRXSNeuraxis Inc1.75%-79.15%
IMABI-Mab1.77%-78.94%
IFRXInflaRx N.V.2.23%-73.46%
ENTOEntero Therapeutics, Inc. Common Stock2.51%-70.14%
GANXGain Therapeutics Inc2.67%-68.27%
NCNANuCana plc3.04%-63.83%
SXTP60 Degrees Pharmaceuticals Inc3.29%-60.87%
IMTXImmatics N.V3.31%-60.63%
YMABY-Mabs Therapeutics Inc3.66%-56.45%
IRONDisc Medicine Inc4.27%-49.25%
BDRXBiodexa Pharmaceuticals Plc4.38%-47.88%
SVASinovac Biotech Ltd4.55%-45.89%
LGVNLongeveron Inc - Class A4.67%-44.47%
MOLNMolecular Partners AG4.89%-41.88%
NCELNLS Pharmaceutics Ltd4.90%-41.74%
ADAGAdagene Inc5.23%-37.75%
PRTCPureTech Health plc American Depositary Shares5.56%-33.80%
ALXOAlx Oncology Holdings Inc5.62%-33.08%
REGNRegeneron Pharmaceuticals Inc6.32%-24.80%
ANROAlto Neuroscience Inc6.58%-21.67%
MDXGMimedx Group Inc7.24%-13.83%
GDTCCytoMed Therapeutics Ltd7.37%-12.27%
MRNAModerna Inc7.96%-5.24%
BEAMBeam Therapeutics Inc8.60%+2.38%
PBYIPuma Biotechnology Inc8.79%+4.54%
PYPDPolypid Ltd9.00%+7.13%
KURAKura Oncology Inc9.04%+7.52%
SLNOSoleno Therapeutics Inc10.06%+19.68%
VRAXVirax Biolabs Group Ltd - Class A10.13%+20.50%
RIGLRigel Pharmaceuticals11.25%+33.89%
MAZEMaze Therapeutics Inc11.36%+35.22%
ABEOAbeona Therapeutics Inc12.48%+48.48%
CLDICalidi Biotherapeutics Inc12.62%+50.20%
ASBPAspire Biopharma Holdings Inc12.90%+53.54%
ACIUAC Immune SA13.65%+62.39%
MNMDMind Medicine (MindMed) Inc. Common Shares14.62%+73.97%
VERAVera Therapeutics Inc - Class A15.01%+78.65%
ALTAltimmune Inc15.25%+81.40%
NUVBNuvation Bio Inc - Class A16.62%+97.77%
SVRASavara Inc17.08%+103.22%
ACHVAchieve Life Sciences Inc17.21%+104.81%
DYNDyne Therapeutics Inc17.27%+105.45%
HRMYHarmony Biosciences Holdings Inc17.45%+107.57%
SPRBSpruce Biosciences Inc18.66%+121.97%
RCUSArcus Biosciences Inc19.08%+127.06%
INVAInnoviva Inc19.24%+128.89%
MDWDMediWound Ltd19.62%+133.41%
TARSTarsus Pharmaceuticals Inc20.80%+147.53%
XNCRXencor Inc21.05%+150.44%
MESOMesoblast Ltd21.45%+155.23%
TCRXTscan Therapeutics Inc22.51%+167.78%
APLSApellis Pharmaceuticals Inc22.59%+168.82%
REPLReplimune Group Inc22.62%+169.16%
CNTACentessa Pharmaceuticals plc22.66%+169.63%
BMRNBiomarin Pharmaceutical Inc23.02%+173.94%
TSHATaysha Gene Therapies Inc23.10%+174.86%
FBIOFortress Biotech Inc23.12%+175.07%
HYFTMindWalk Holdings Corp23.71%+182.16%
ONCBeiGene Ltd24.13%+187.16%
LXRXLexicon Pharmaceuticals Inc24.49%+191.41%
NKTRNektar Therapeutics24.89%+196.17%
ICCCImmucell Corp29.87%+255.38%
CRSPCRISPR Therapeutics AG32.27%+283.90%
ZLABZai Lab Ltd32.30%+284.31%
QUREuniQure N.V.33.44%+297.89%
ABOSAcumen Pharmaceuticals Inc35.49%+322.29%
ALDXAldeyra Therapeutics Inc36.29%+331.82%
PRQRProQR Therapeutics N.V36.40%+333.13%
OBIOOrchestra BioMed Holdings Inc36.41%+333.27%
COGTCogent Biosciences Inc36.72%+336.96%
ELABPMGC Holdings Inc37.62%+347.59%
MLTXMoonLake Immunotherapeutics - Class A38.98%+363.79%
LEGNLegend Biotech Corp40.23%+378.66%
PHXMPHAXIAM Therapeutics SA ADR42.62%+407.15%
PHARPharming Group N.V.43.21%+414.06%
XFORX4 Pharmaceuticals Inc44.52%+429.75%
ADMAAdma Biologics Inc50.44%+500.10%
SRPTSarepta Therapeutics Inc55.69%+562.58%
BLRXBioline Rx Ltd55.78%+563.70%
ARQTArcutis Biotherapeutics Inc57.70%+586.48%
MDGLMadrigal Pharmaceuticals Inc62.62%+645.10%
CAICaris Life Sciences Inc - Class A64.29%+664.97%
SRRKScholar Rock Holding Corp71.23%+747.55%
INSMInsmed Inc76.93%+815.28%
ATAIATAI Life Sciences N.V.83.95%+898.88%
VRNAVerona Pharma Plc87.12%+936.57%
IONSIonis Pharmaceuticals Inc88.01%+947.17%
RYTMRhythm Pharmaceuticals Inc88.25%+950.05%
RPRXRoyalty Pharma plc - Class A90.13%+972.43%
CDXSCodexis Inc93.64%+1014.11%
ALECAlector Inc94.08%+1019.33%
GMABGenmab94.17%+1020.50%
TTRXTurn Therapeutics Inc97.04%+1054.61%
GERNGeron Corp109.92%+1207.86%
XOMAXOMA Corp110.73%+1217.44%
HCWBHCW Biologics Inc114.14%+1258.04%
JAZZJazz Pharmaceuticals plc118.15%+1305.71%
MRVIMaravai LifeSciences Holdings Inc - Class A119.30%+1319.49%
TLXTelix Pharmaceuticals Ltd126.06%+1399.93%
TGTXTG Therapeutics Inc127.78%+1420.38%
ARDXArdelyx Inc136.94%+1529.28%
FOLDAmicus Therapeutics Inc143.18%+1603.58%
QNTMFSD Pharma Inc - Class B - Class B (Sub Voting)146.17%+1639.18%
AAPGAscentage Pharma Group International149.47%+1678.46%
OPTOpthea Ltd156.18%+1758.25%
SPRYARS Pharmaceuticals Inc157.44%+1773.22%
NMRANeumora Therapeutics Inc159.82%+1801.60%
MISTMilestone Pharmaceuticals Inc161.42%+1820.66%
CLLSCellectis181.25%+2056.52%
ASNDAscendis Pharma A/S183.75%+2086.32%
FTREFORTE SOFTWARE INC200.32%+2283.48%
CELCCelcuity Inc257.58%+2964.78%
HOWLWerewolf Therapeutics Inc262.95%+3028.60%
VALNValneva SE273.15%+3150.01%
ALLRAllarity Therapeutics Inc290.17%+3352.53%
HUMAHumacyte Inc308.59%+3571.70%
AXSMAxsome Therapeutics Inc344.13%+3994.50%
ADAPAdaptimmune Therapeutics plc American Depositary Shares423.98%+4944.58%
PGENPrecigen Inc462.16%+5398.90%
OCGNOcugen Inc502.91%+5883.71%
SNDXSyndax Pharmaceuticals Inc840.90%+9905.17%
HALOHalozyme Therapeutics Inc976.45%+11517.96%
EDITEditas Medicine Inc1240.40%+14658.51%
RVNCRevance Therapeutics Inc1477.84%+17483.56%
IOBTIO Biotech Inc1829.20%+21664.08%